NCT01561274View on ClinicalTrials.gov

ET 50 for Post Caesarean Section Spinal Hypotension

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

March 31, 2014

Study Completion Date

May 31, 2014

Conditions
Hypotension
Interventions
DRUG

2 ml bupivacaine

2 ml bupivacaine

DRUG

1.5 ml bupivicaine.

1.5 ml bupivicaine.

Trial Locations (1)

Unknown

Royal Victoria Hospital, Montreal

All Listed Sponsors
lead

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

NCT01561274 - ET 50 for Post Caesarean Section Spinal Hypotension | Biotech Hunter | Biotech Hunter